• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Alimera Sciences Inc

+ Add to Watchlist

ALIM:US

4.9500 USD 0.1300 2.56%

As of 20:10:00 ET on 09/17/2014.

Snapshot for Alimera Sciences Inc (ALIM)

Open: 5.0800 Day's Range: 4.8900 - 5.1600 Volume: 217,654
Previous Close: 5.0800 52wk Range: 1.6500 - 8.4400 1-Yr Rtn: +25.63%

Stock Chart for ALIM

No chart data available.
  • ALIM:US 4.9400
  • 1D
  • 1M
  • 1Y
5.0800
Interactive ALIM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALIM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7961
Est. EPS (USD) (12/2014) -1.0400
Est. PEG Ratio -
Market Cap (M USD) 200.10
Shares Outstanding (M) 40.42
30 Day Average Volume 118,408
Price/Book (mrq) -
Price/Sale (ttm) 29.8054
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/11/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALIM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ALIM

Alimera Sciences Inc. is a biopharmaceutical company. The Company researches, develops and commercializes prescription ophthalmic pharmaceuticals. Alimera Sciences is focused on diseases affecting the lining in the back of the eye, or retina.

C Daniel Myers "Dan"President/CEO/Co-FounderRichard S Eiswirth Jr "Rick"CFO/COO/Secretary
Kenneth Green "Ken"Senior VP/Chief Scientific OfcrDavid Holland "Dave"Senior VP:Sales & Marketing
More Company Profile & Key Executives for ALIM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil